Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Cai

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Internal Medicine Journal|June 7, 2022
The disproportionately large contribution of the Māori and Pacific Islander community to the healthcare burden of gout in Western SydneyPeter K K Wong, Beverly C K Ng, James Mitchell, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working groupKen Cai, Amy Fuller, Owen Hensey, et al.
Arthritis Research & Therapy|December 8, 2021
Development of a radiographic scoring system for new bone formation in goutChang-Nam Son, Ken Cai, Sarah Stewart, et al.
Seminars in Arthritis and Rheumatism|January 19, 2021
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Cesar Diaz-Torne, et al.
Seminars in Arthritis and Rheumatism|May 4, 2021
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Georgios Filippou, et al.
Seminars in Arthritis and Rheumatism|June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition diseaseNicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working groupKen Cai, Amy Fuller, Yiling Zhang, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Internal Medicine Journal|June 7, 2022
The disproportionately large contribution of the Māori and Pacific Islander community to the healthcare burden of gout in Western SydneyPeter K K Wong, Beverly C K Ng, James Mitchell, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working groupKen Cai, Amy Fuller, Owen Hensey, et al.
Arthritis Research & Therapy|December 8, 2021
Development of a radiographic scoring system for new bone formation in goutChang-Nam Son, Ken Cai, Sarah Stewart, et al.
Seminars in Arthritis and Rheumatism|January 19, 2021
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Cesar Diaz-Torne, et al.
Seminars in Arthritis and Rheumatism|May 4, 2021
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Georgios Filippou, et al.
Seminars in Arthritis and Rheumatism|June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition diseaseNicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working groupKen Cai, Amy Fuller, Yiling Zhang, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Pageof 4